Sentences with phrase «genetic research strategy»

The assumptions underlying this genetic research strategy are made explicit, together with its strengths and limitations.

Not exact matches

If they are not experts in your field they can not judge how long a genetic experiment or molecular biology strategy can take, and they may get lost in the details and simply think that you have formulated your research wrongly.»

Researchers from the Stowers Institute for Medical Research in collaboration with Fred Hutchinson Cancer Research Center researchers have identified an unprecedented genetic survival strategy that would be right at home in an Agatha Christie murder mystery novel.

While the study findings are significant, much more research is needed to refine the genetic engineering strategy, said Egan.

«You can slow the rate of spread of a pathogen and even deter bugs by growing multiple varieties that have different genetic strategies for defending themselves,» says Ted Wilson, director of Texas A & M University's AgriLife Research Center.

A team of researchers at Mayo Clinic and The Scripps Research Institute in Florida have developed a new therapeutic strategy to combat the most common genetic risk factor for the neurodegenerative disorders amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and frontotemporal dementia (FTD).

Our study will help researchers develop a strategy for genetic research and prioritising sample collection.

In addition to their work with the Neonatal Research Network studying strategies to improve outcomes for preterm babies, the Duke researchers continue to study environmental and genetic factors, as well as the babies» gut bacteria and metabolomics.

The strategy developed by research teams and development of I - Stem aims to identify innovative therapies applicable to rare genetic diseases based on exploring the potential offered by human pluripotent stem cells.

«This agreement is a part of deCODE's ongoing strategy to unleash the value of human genetics,» said Kari Stefansson, founder and CEO of deCODE, «our research platform allows us to understand the genetic basis of disease and modifiers of clinical phenotypes in actual patient populations; by doing so, we can rapidly move from targets to patient stratification and from there to companion diagnostics.»

Having determined a strategy and a work plan Genetic Alliance UK then seeks resources to implement it from a wide range of potential funders including National Governments, the EU, the pharmaceutical and medical devices industry, the Medical Research Council, Wellcome Trust, The Big Lottery and others.

deCODE's genetic research is aimed at identifying the genetic factors involved, as a means of identifying new drug and diagnostic targets that can target the underlying cause of disease and point the way towards more effective treatment and prevention strategies.

The Foundation uses a variety of strategies — workshops, grants, fellowships, and targeted research contracts — to solve the mysteries of genetic disease and develop new treatments and cures.

The research team collaborated with molecular biotechnologist Leroy Hood of the Institute of Systems Biology in Seattle, Washington, using a whole genome shotgun strategy to obtain the genetic data.

This is a collaboration with the International Rice Research Institute (IRRI) in the Philippines, and the objective is to use pre-breeding strategies to explore the genetic potential of wild and unadapted rice germplasm and to enlarge the gene pool that is utilized for routine plant improvement.

The scope and terms of reference of an advisory body would include all companion animals; consider the best ways forward for tackling genetic welfare problems on a breed by breed (or strain) basis; advise and promote the development of breeding strategies; make recommendations about research priorities; and communicate its findings effectively.

His current research emphases are on 1) pain in farm animals, following various management practices, such as beak trimming in poultry; 2) genetic selection for improving animal well - being; 3) preventing aggression by modification of the serotonin system; 4) developing intervention strategies for increasing heat tolerance; and 5) developing alternative housing systems for improving animal health and production.

Their research could be used to help identify adaptation strategies, potentially including genetic modification or improved plant breeding.

With deep understanding of genetic & biomedical standards, patents & technology transfer and commercial affairs, interested to work with a research organization, where I can get full support from my department to come up with excellent strategies beneficial for the organization.

Tags for this Online Resume: Biotechnology, Diagnostic, Pharmaceutical, Marketing, Oncology, Strategy, Brand Planning, Global Marketing, New Product Planning, Pricing, Market Research, Brand Leader, Commercial, Commercialization, Launch, Drug Development, Matrix, Cross Functional, Digital, KOL, Key Opinion Leader, Portfolio, Management, Brand Team, Agency, Diabetes, Cardiovascular, Commercial Strategy, Corporate Affairs, Communications, Hematology, Urology, Neuroscience, phase 2, phase 3, phase II, phase III, Powerpoint, Excel, Word, Part B, Part D, Seattle, Portland, San Francisco, Executive Director, Senior Director, Director, Vice President, Go - To - Market, Value Proposition, Go To Market, Launch Planning, Access, Reimbursement, Payer, Market Development, Market Assessment, Pipeline, In - Line, Brand Management, Coaching, Leadership, Marketing Strategies, Marketing Strategy, Strategic Planning, Autoimmune, Early Stage, Pre-Launch, Pre Launch, Regulatory, Operations, Marketing Plan, Business Plan, Business Development, Market Analysis, Segmentation, Targeting, Companion Diagnostic, Target Product Profile, Pre-Clinical, Competition, Positoning, Branding, Sales, Budget, Sales Management, Communication Plan, Publication Plan, Project Management, Genetic, Genomic, Lifecycle, Long Range, Device, Late Stage, Direct Report, Indirect Report, New Molecular Entities, Competitive, Biopharmaceutical, Medical Device, Non-Promotional, Tactical, Execution, IND, Revenue, Partner, Clinical, Consult, Analytical, Problem Solver, Global, International, Affordable Care Act, Lymphoma, Leukemia, Prostate, Breast, Cancer, OPDP, Promotional, Promotions, Brand, Healthcare, Distribution, Infrastructure, IMS, Priority Review, Experienced, Patient, Consumer